Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer

Oncotarget

Volumn 7, Issue 1, 2016, Pages 1030-1041

  Zhou, Rui ^a   Wu, Zhenzhen ^a   Zhang, Jingwen ^a   Wang, Hongqiang ^a,b   Su, Yuqi ^a,c   Huang, Na ^a   Shi, Min ^a   Bin, Jianping ^a   Liao, Yulin ^a   Liao, Wangjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Zhoushan Hospital   (China)

^c The First People's hospital of YueYang   (China)

Author keywords

Distant metastatic gastric cancer; LND; Lymph node status; Palliative surgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; RETROSPECTIVE STUDY; STOMACH CANCER; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; CHI SQUARE DISTRIBUTION; KAPLAN MEIER METHOD; LYMPH NODE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; STOMACH; STOMACH NEOPLASMS;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 85015432421     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/ONCOTARGET.6009     Document Type: Article

References (30)

1. Dixon M, Mahar AL, Helyer LK, Vasilevska-Ristovska J, Law C, Coburn NG. Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2014
2. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer. 1993; 72:2089-2097
3. Li Q, Li G, Palmer JD, Zhang Z. Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study. American journal of clinical oncology. 2014
4. Toth D, Torok M, Kincses Z, Damjanovich L. Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2013; 16:201-207
5. Yoshida K, Yamaguchi K, Okumura N, Osada S, Takahashi T, Tanaka Y, Tanabe K, Suzuki T. The roles of surgical oncologists in the new era: minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer. Pathobiology: journal of immunopathology, molecular and cellular biology. 2011; 78:343-352
6. Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, Andreola S. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surgery, gynecology & obstetrics. 1987; 164:151-154
7. Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2013; 119:1636-1642
8. Reim D, Loos M, Vogl F, Novotny A, Schuster T, Langer R, Becker K, Hofler H, Siveke J, Bassermann F, Friess H, Schuhmacher C. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. Journal of clinical oncology. 2013; 31:263-271
9. Sun Z, Wang ZN, Zhu Z, Xu YY, Xu Y, Huang BJ, Zhu GL, Xu HM. Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Annals of surgical oncology. 2012; 19:1918-1927
10. Ke B, Song XN, Liu N, Zhang RP, Wang CL, Liang H. Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection. PloS one. 2014; 9:e96455
11. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. Journal of the American College of Surgeons. 1998; 187:597-603
12. Lee SR, Kim HO, Son BH, Shin JH, Yoo CH. Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World journal of surgery. 2012; 36:1096-1101
13. Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Annals of surgical oncology. 2009; 16:319-326
14. Zhou Y, Zhang J, Cao S, Li Y. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric cancer. 2013; 16:309-317
15. Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Annals of surgery. 2012; 255:478-485
16. Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz HJ. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. Journal of gastrointestinal oncology. 2011; 2:77-84
17. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric cancer. 2007; 10:153-158
18. Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Annals of surgery. 2012; 255:50-58
19. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. Journal of clinical oncology. 2005; 23:7114-7124
20. Sobin LH GM, Wittekind C. TNM Classification of Malignant Tumours. Wiley Weinheim, Germany, (7th edition). 2010:455
21. Greene FL PD, Fleming ID, et al. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6th edition. New York, NY: Springer-Verlag; 2002
22. Moertel CG, Gunderson LL, Mailliard JA, McKenna PJ, Martenson JA Jr., Burch PA, Cha SS. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. Journal of clinical oncology. 1994; 12:21-27
23. Moertel CG, Childs DS Jr., Reitemeier RJ, Colby MY Jr., Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969; 2:865-867
24. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Annals of surgical oncology. 2007; 14:317-328
25. Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ, Wang JB. Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World journal of gastroenterology: WJG. 2010; 16:2055-2060
26. Valsangkar NP, Bush DM, Michaelson JS, Ferrone CR, Wargo JA, Lillemoe KD, Fernandez-del Castillo C, Warshaw AL, Thayer SP. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. Journal of gastrointestinal surgery. 2013; 17:257-266
27. Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PloS one. 2012; 7:e49424
28. Kaplan EL MP. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457-481
29. Peto RP. Conservatism in the approximation E(0-E)2/E in the log rank test for survival data or tumor incidence data. Biometrics. 1973; 29:579-584
30. DR C. Regression models and life tables. J R Stat Soc B. 1972; 34:187-220